Hepatitis viruses - Heptatitis A, B, C, D and E, clinical features, epidemiology and lab diagnosis
-
Upload
ashish-jawarkar -
Category
Health & Medicine
-
view
418 -
download
0
description
Transcript of Hepatitis viruses - Heptatitis A, B, C, D and E, clinical features, epidemiology and lab diagnosis
HEPATITIS VIRUSES
Dr. Ashish V. JawarkarM.D. (Pathology)
Dr. Ashish Jawarkar Hepatitis viruses 2
Hepatitis Infection of liver Hepatitis viruses – A, B, C, D, E and G B – DNA virus All others – RNA viruses Cause icteric jaundice
Type A and E – food borne, feco oral route Type B and C – Blood borne, parenteral and
sexual routes
Dr. Ashish Jawarkar Hepatitis viruses 3
Hepatitis A
Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment
Dr. Ashish Jawarkar Hepatitis viruses 4
Epidemiology
Common in children Feco oral route – contaminated water
or milk Over crowding and poor sanitation Ingested, reaches intestine,
penetrates epithelium, reaches liver through blood
Dr. Ashish Jawarkar Hepatitis viruses 5
Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment
Dr. Ashish Jawarkar Hepatitis viruses 6
Clinical features
2-6 weeks incubation period – asymptomatic
Clinical symptoms – malaise, anorexia, nausea, vomitting and abdominal pain
Yellow urine
Dr. Ashish Jawarkar Hepatitis viruses 7
Dr. Ashish Jawarkar Hepatitis viruses 8
Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment
Dr. Ashish Jawarkar Hepatitis viruses 9
Lab diagnosis
Raised bilirubin in serum (indirect>direct)
Yellow urine – bilirubin present Demonstration of antibodies by ELISA
IgM – recent infection IgG – remote infection
Dr. Ashish Jawarkar Hepatitis viruses 10
Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment
Dr. Ashish Jawarkar Hepatitis viruses 11
Prophylaxis
Improved sanitation Vaccine is available Natural infection leads to life long
immunity
Dr. Ashish Jawarkar Hepatitis viruses 12
Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment
Dr. Ashish Jawarkar Hepatitis viruses 13
Treatment
No antiviral drug available Treatment is symptomatic
Dr. Ashish Jawarkar Hepatitis viruses 14
TYPE B HEPATITIS
Over 350 million HBV carriers in the world
One million die anually
Dr. Ashish Jawarkar Hepatitis viruses 15
Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment
Dr. Ashish Jawarkar Hepatitis viruses 16
Epidemiology
Hepatitis B virus structure
Dr. Ashish Jawarkar Hepatitis viruses 17
In the serum of Hep B patients we can see – Australia antigen or
Dr. Ashish Jawarkar Hepatitis viruses 18
Dane particle
Dr. Ashish Jawarkar Hepatitis viruses 19
Developed countries
Adolscents and young adults Infection occurs through
contaminated syringes and needles Drug addicts Homosexuals
Dr. Ashish Jawarkar Hepatitis viruses 20
Developing countries
Children Vertical transmission from mother to
baby Horizontal transmission among
infants and neonates
Dr. Ashish Jawarkar Hepatitis viruses 21
Everywhere
Razors, nail clippers, acupuncture, tatooing, circumscision, ear or nose piercing
Barbers, dentists and doctors may get infected
Dr. Ashish Jawarkar Hepatitis viruses 22
Carriers
Those who donot have symptoms but are HbsAg positive
Dr. Ashish Jawarkar Hepatitis viruses 23
Screening of blood donors
Compulsory
Dr. Ashish Jawarkar Hepatitis viruses 24
Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment
Dr. Ashish Jawarkar Hepatitis viruses 25
Clinical features
No symptoms in carriers Similar to HAV in acute phase
Dr. Ashish Jawarkar Hepatitis viruses 26
Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment
Dr. Ashish Jawarkar Hepatitis viruses 27
Lab diagnosis
Demonstration of viral antibodies and antigens in serum -
Dr. Ashish Jawarkar Hepatitis viruses 28
Dr. Ashish Jawarkar Hepatitis viruses 29
HBsAg infection IgM anti HBcAg recent
infection IgG anti HBcAg remote
infection HBeAg infective Anti HBsAg immunity after
vaccination
Dr. Ashish Jawarkar Hepatitis viruses 30
Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment
Dr. Ashish Jawarkar Hepatitis viruses 31
Prophylaxis
Avoid multiple partners Avoid drug abuse Use of disposable syringes and
needles Screening of Blood, organ and semen
donors Universal immunisation (vaccination)
Dr. Ashish Jawarkar Hepatitis viruses 32
Immunisation - Passive
administer HBIG (Hepatitis B immunoglobulin)
Administer soon after accidental exposure
Can be administered to baby born to a carrier mother
Dr. Ashish Jawarkar Hepatitis viruses 33
Active immunisation - vaccine
Consists of HBsAg particles Given as a routine to all babies
Dr. Ashish Jawarkar Hepatitis viruses 34
Epidemiology Clinical features Lab diagnosis Prophylaxis Treatment
Dr. Ashish Jawarkar Hepatitis viruses 35
Treatment
Acute phase – no treatment required, patients recover
Chronic phase – become carriers, can give antivirals like lamivudine and adefovir to keep replication in check
Dr. Ashish Jawarkar Hepatitis viruses 36
Hepatitis C Virus
Also blood borne Most common cause of post
transfusion hepatitis in developed countries
Most common cause of post hepatitis – hepatocellular carcinoma
Dr. Ashish Jawarkar Hepatitis viruses 37
Hepatitis E virus
Feco oral route Second common cause of hepatitis
after hepatitis A in developing countries
Generally mild and self limiting illness Unusually high mortality (20-40 %) in
pregnancy
Dr. Ashish Jawarkar Hepatitis viruses 38